Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Perifosine Continues To Show Strong Anti-Cancer Results: Multiple Myeloma Perifosine Update

Home/Uncategorized/Perifosine Continues To Show Strong Anti-Cancer Results: Multiple Myeloma Perifosine Update

Perifosine Continues To Show Strong Anti-Cancer Results: Multiple Myeloma Perifosine Update

Keryx’s perifosine gets second orphan drug status
(AP) – 10 hours ago
NEW YORK — Keryx Biopharmaceuticals Inc. said Wednesday that its experimental cancer drug perifosine received orphan drug status as a treatment for neuroblastoma, a cancer that affects the nervous system and mostly strikes young children…
Perifosine also has orphan drug status as a colorectal cancer treatment, and the FDA has said it will conduct a faster-than-normal review of the drug in both colorectal cancer and multiple myeloma.

Read the entire release by going to:  Associated Press story about Keryx Biopharmaceuticals’ perifosine
Promising!  Feel good and keep smiling!  Pat